Rationale, design, and baseline characteristics of a Program to Assess and Review Trending INformation and Evaluate CorRelation to Symptoms in Patients with Heart Failure (PARTNERS HF)

American Heart Journal

Volumn 156, Issue 5, 2008, Pages

  Whellan, David J ^a   O'Connor, Christopher M ^b   Ousdigian, Kevin T ^c   Lung, Te Hsin ^c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c MEDTRONIC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATOR; DIAGNOSTIC PROCEDURE; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HEART FAILURE; HUMAN; LUNG CONGESTION; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TIME SERIES ANALYSIS;

EID: 54349096046     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.06.036     Document Type: Article

References (35)

1. Thom T., Haase N., Rosamond W., et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113 (2006) e85-e151
2. Rich M.W. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc 45 (1997) 968-974
3. Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 (2002) 1845-1853
4. Cleland J.G.F., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
5. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
6. Young J.B., Abraham W.T., Smith A.L., et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure. The MIRACLE ICD Trial. JAMA 289 (2003) 2685-2694
7. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
8. AVID Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337 (1997) 1576-1583
9. Casolo G.C., Stroder P., Sulla A., et al. Heart rate variability and functional severity of congestive heart failure secondary to coronary artery disease. Eur Heart J 16 (1995) 360-367
10. Moss A.J., Greenberg H., Case R.B., et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 110 (2004) 3760-3765
11. Muller D., Lampe F., Wegscheider K., et al. Annual distribution of ventricular tachycardias and ventricular fibrillation. Am Heart J 146 (2003) 1061-1065
12. Deedwania P.C., Singh B.N., Ellenbogen K., et al. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHFSTAT). The Department of Veterans Affairs CHF-STAT Investigators. Circulation 98 (1998) 2574-2579
13. Singh S.N., Fletcher R.D., Fisher S.G., et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med 333 (1995) 77-82
14. Pozzoli M., Cioffi G., Traversi E., et al. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol 32 (1998) 197-204
15. Mathew J., Hunsberger S., Fleg J., et al. Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure. Chest 118 (2000) 914-922
16. Dries D.L., Exner D.V., Gersh B.J., et al. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 32 (1998) 695-703
17. Khan M.N., Kozelhova M., Patel D., et al. Hospitalization due to atrial fibrillation in patients with cardiac resynchronization therapy. [abstract]. Heart Rhythm 3 Suppl 1 (2006) S253 Abstract P4-104
18. Ousdigian K.T., Johnson W.B., Koehler J.L., et al. Newly recognized atrial tachyarrhythmias are fairly common and increase the risk of supraventricular shocks and cardiovascular hospitalizations in ICD patients [abstract]. Heart Rhythm 3 Suppl 1 (2006) S162 Abstract P2-72
19. Capucci A., Santini M., Padeletti L., et al. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol 46 (2005) 1913-1920
20. Strickberger S.A., Ip J., Saksena S., et al. Relationship between atrial tachycardias and symptoms. Heart Rhythm 2 (2005) 125-131
21. Israel C.W., Groenfeld G., Ehrlich J.R., et al. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol 43 (2004) 47-52
22. Ziegler P.D., Koehler J.L., and Mehra R. Comparison of continuous vs. intermittent monitoring of atrial arrhythmias. Heart Rhythm 3 (2006) 1445-1452
23. Levy T., Walker S., Mason M., et al. Importance of rate control or rate regulation for improving exercise capacity and quality of life in patients with permanent atrial fibrillation and normal left ventricular function: a randomized controlled study. Heart 85 (2001) 171-178
24. Wilkoff B.L., Ousdigian K.T., Johnson W.B., et al. New continuous atrial tachyarrhythmia rate control diagnostic reveals significantly more patients have poor rate control then discovered via intermittent evaluations. [abstract]. Heart Rhythm 3 Suppl 1 (2006) 127-128 Abstract P161
25. Ousdigian K.T., Johnson W.B., Koehler J.L., et al. Very poor rate control during atrial tachyarrhythmias predicts cardiovascular hospitalizations. [abstract]. J Card Fail 12 Suppl 1 (2006) S57-S58 Abstract 187
26. Willems R., Morck M.L., Exner D.V., et al. Ventricular high-rate episodes in pacemaker diagnostics identify a high risk subgroup of patients with tachy-brady syndrome. Heart Rhythm 4 (2004) 414-421
27. Knight B.P., Desai A., Coman J., et al. Long-term retention of cardiac resynchronization pacing. J Am Coll Cardiol 44 (2004) 72-77
28. Ousdigian K.T., Thompson D., Qi D., et al. A single day of AF with poor rate control predicts a subsequent week of reduced CRT [abstract]. Heart Rhythm (2007)
29. Jiang W., Hathaway W., McNulty S., et al. Ability of heart rate variability to predict prognosis in patients with advanced congestive heart failure. Am J Cardiol 80 (1997) 808-811
30. Fauchier L., Babuty D., Cosnay P., et al. Heart rate variability in idiopathic dilated cardiomyopathy: characteristics and prognostic value. J Am Coll Cardiol 30 (1997) 1009-1014
31. Nolan S.P., Crampton R.S., McGuire L.B., et al. Factors influencing survival of patients with permanent cardiac pacemakers. Ann Surg 185 (1977) 122-127
32. Adamson P.B., Smith A.L., Abraham W.T., et al. Continuous autonomic assessment in patients with symptomatic heart failure. Circulation 110 (2004) r39-r44
33. Yu C.M., Wang L., Chau E., et al. Intrathoracic impedance monitoring in patients with heart failure. Circulation 112 (2005) 841-848
34. Yu C.M., Chau E., Lau C.P., et al. Intrathoracic impedance: a surrogate measure of fluid retention and predictor of hospitalization in study participants with heart failure. J Am Coll Cardiol 41 (2005) 210A
35. Packer M., Abraham W.T., Mehra M.R., et al. Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. J Am Coll Cardiol 47 (2006) 2245-2252